Woman sitting on couch looking out a window
·
5 Min Read

Reducing access to mifepristone would harm patients

Scientific evidence overwhelmingly demonstrates mifepristone’s safety. Reimposing limits on its use will harm patients and undermine the nation’s longstanding drug-approval system.

series
Leadership
Leadership Viewpoints
Advocacy Insights webinar logo
Apr 15, 2024 ·
43 Min Read

AMA Advocacy Insights webinar series: What we need to do—now—to address the maternal health crisis

In this Advocacy Insights webinar, learn about the AMA’s newly released recommendations on maternal health and what approaches are needed.

series
Events
Advocacy Insights Webinar Series
A cherry tree in bloom near the U.S. Supreme Court
·
5 Min Read

Why high court shouldn’t interfere with FDA’s science-based decisions

Mifepristone saves lives and is as safe as ibuprofen. The AMA and other medical associations urge the Supreme Court to respect FDA expertise, authority.

Judicial Advocacy
AMA Update for March 18, 2024: Measles outbreak 2024, why measles is back in the US, and FDA approved OTC birth control pills (index only)
·
10 Min Read

Measles outbreak 2024, why measles is back in the US, and FDA approved OTC birth control pills

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the measles outbreak of 2024.

series
Infectious Diseases
AMA Update
·
10 Min Read

Measles outbreak 2024, why measles is back in the US, and FDA approved OTC birth control pills [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the measles outbreak of 2024.

series
Infectious Diseases
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of March 11, 2024

In the news: Medicare drug price negotiations, ongoing fallout from hack of UnitedHealth’s Change Healthcare, data errors in maternal mortality rate and more.

Publications & Newsletters
·
7 Min Read

March 8, 2024: State Advocacy Update

New AMA report on overdose crisis in pregnant and postpartum people and more in the latest State Advocacy Update.

Advocacy Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 4, 2024

In the news: Ongoing fallout from ChangeHealthcare cyberattack, OTC birth control will soon be available in stores, microplastics link to risk of heart attack and stroke, and more.

Publications & Newsletters
AMA Update for March 6, 2024: New USPSTF screening guidelines for anxiety, plus PrEP, depression and hypertension in pregnancy
·
7 Min Read

New USPSTF screening guidelines for anxiety, plus PrEP, depression and hypertension in pregnancy

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about preventive screenings.

series
Behavioral Health
AMA Update